Cite
HARVARD Citation
Borges, M. et al. (2020). Cost-effectiveness of sacubitril/valsartan for the treatment of patients with heart failure with reduced ejection fraction in Portugal. Expert review of pharmacoeconomics & outcomes research. pp. 199-205. [Online].